You are here
Validation of a panel of cell-cycle progression genes for improved risk stratification in a contemporary radical prostatectomy cohort.
Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^).
Abstracts by Matthew R. Cooperberg:
Analysis of the PROCEED registry by baseline prostate-specific antigen (PSA) quartiles: Preliminary analysis of real-world sipuleucel-T (sip-T) use.Meeting: 2016 Genitourinary Cancers Symposium | Abstract No: 193
Change in a 17-gene genomic prostate score over time in men with low- and intermediate-risk prostate cancer managed with active surveillance.Meeting: 2016 Genitourinary Cancers Symposium | Abstract No: 124
Changing characteristics of patients treated with sipuleucel-T (sip-T) over time: Real-world experience from the PROCEED registry.Meeting: 2016 Genitourinary Cancers Symposium | Abstract No: 320
Presentations by Matthew R. Cooperberg:
Meeting: 2013 Genitourinary Cancers Symposium
Session: General Session I: Prostate Cancer: Active Surveillance and Screening (General Session)